Cyclothymic Disorder

A mood disorder that causes emotional highs and lows.

The mood shifts in cyclothymia aren’t as extreme as those in people with bipolar disorders. People with cyclothymia can typically function in daily life, though it may be difficult.

Symptoms include intermittent psychological highs and lows that may become more pronounced over time.

Treatment usually involves counseling and therapy. In rare cases, medications may be used.


Cluster Number:
Wiki Number: W051
Diagnosis: Cyclothemic Disorder
US Patients:
World Patients:
Sex Ratio: M1;F1
Age Onset: Age 17
Brain Area:
Symptoms: mild depressive symptoms periodically, usually in a family with bipolar disorder; mentally and socially withdrawn
Progression: rotate between depressive and mild manic states with more spontaneity, self-esteem, spending; thoughts faster
Medications: lithium, mood stabilizers
Therapies: counseling


The world-wide medical research
reports chosen for each diagnosis 

Clicking each title opens the
PubMed article’s summary-abstract.

  • Acute and Maintenance Treatment of Bipolar Depression
    by Evrim Erten on October 18, 2021

    The World Health Organization reported a lifetime prevalence of 2.4% for BD-I, BD-II and sub-threshold types of bipolar disorder (BD). Depressive episodes are more common than manic episodes for many BD patients. Studies show that depressive mood persists in 2/3 of life, even if they are under treatment. It may be difficult to diagnose BD in the event of depression in the first episode. The correct diagnosis and the treatment can be delayed for 6-8 years, and even longer if disorder starts in...

  • Sensitivity and concurrent validity of the Japanese version of the Euthymia scale: a clinimetric analysis
    by Natsu Sasaki on October 5, 2021

    CONCLUSIONS: The findings of the present study indicated that the ES-J is a valid and highly sensitive clinimetric index, which can be used as a screening measure in the clinical process of assessment of recovery, particularly when symptoms are expected to be mild and/or when dealing with subclinical symptoms of psychological distress and depression. The findings of this study also support the use of the ES-J to detect vulnerability to depression and to identify subjects at higher risk of...

  • Early intervention in bipolar affective disorders: Why, when and how
    by A Pouchon on September 27, 2021

    CONCLUSIONS: EIS for psychosis might consider developing and implementing screening and treatment approaches for individuals experiencing an early stage of BD. Several opportunities for progress on early intervention in the early stages of BD can be drawn. Training first-line practitioners to identify at-risk subjects would be relevant to optimize screening of this population. Biomarkers including functional and structural imaging measures of specific cortical regions and inflammation proteins...

  • Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings
    by Daria Piacentino on September 16, 2021

    CONCLUSIONS: Our results have implications for studying AAS users, as they identify a cluster of variables that may be relevant in future understanding of AAS use risks (e.g., personality disorders). Possible disagreements between AAS assessment methods should be considered when implementing harm reduction interventions, such as needle and syringe distribution, health education, and counselling, as well as surveillance programmes.